<DOC>
	<DOCNO>NCT02974738</DOCNO>
	<brief_summary>The primary objective study identify maximum tolerate dose ( MTD ) PT2977 Tablets and/or recommend Phase 2 dose ( RP2D ) PT2977 Tablets patient advance solid tumor</brief_summary>
	<brief_title>A Trial PT2977 Tablets In Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>Part 1A : This Phase 1 , multiple-dose , dose-escalation trial PT2977 Tablets , patient advance solid tumor assign sequential dose cohort . Patient safety monitor frequent physical examination , vital sign measurement , electrocardiogram ( ECGs ) , hematology chemistry laboratory study , record adverse event ( AEs ) . Blood obtain analysis concentration PT2977 ass biomarkers . Part 1B : Once MTD and/or RP2D achieve , expansion cohort 25 patient advance clear cell renal cell carcinoma ( ccRCC ) enrol . Part 2 : After determination MTD/RP2D , 25 patient specify solid tumor may enrol . Up 3 different tumor type may include part study .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma , Clear Cell</mesh_term>
	<criteria>Has diagnosis locally advance metastatic solid tumor Is age ≥ 18 year Has life expectancy ≥ 3 month Has adequate organ function If female patient , must surgically sterile , postmenopausal , must agree use physicianapproved method birth control study minimum 30 day last study drug administration , male patient female partner , must agree use physicianapproved method birth control study minimum 30 day last study drug administration Able swallow oral medication Has history untreated brain metastasis history leptomeningeal disease spinal cord compression Has fail recover reversible effect prior anticancer therapy Has uncontrolled poorly control hypertension Has malabsorption due prior gastrointestinal ( GI ) surgery GI disease Has major cardiovascular event within 6 month prior study drug administration Has clinically significant cardiac , respiratory , medical psychiatric condition might interfere participation trial interfere interpretation trial result Has major surgery within 4 week first study drug administration Has know HIV Has active infection require systemic treatment Is participate another therapeutic clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>